Mid
J
JNJAI Stock Diagnostic Report
J&J wins FDA label expansion for Imaavy in wAIHA
Johnson & Johnson (J&J) has received FDA approval for the expanded indication of its rare autoimmune disease treatment, 'Imaavy'.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
JNJ Analysis History (Last 30 Days)